➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Boehringer Ingelheim
AstraZeneca
Colorcon

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Histidine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Histidine?

Histidine is an investigational drug.

There have been 25 clinical trials for Histidine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Syndrome, Menkes Kinky Hair Syndrome, and Malaria, Falciparum. The leading clinical trial sponsors are China Medical University Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Cardiovascular Center Harapan Kita Hospital Indonesia.

There are two US patents protecting this investigational drug and forty-four international patents.

Recent Clinical Trials for Histidine
TitleSponsorPhase
Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABGAin Shams UniversityEarly Phase 1
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)Cures Within ReachPhase 1/Phase 2
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)University of MichiganPhase 1/Phase 2

See all Histidine clinical trials

Clinical Trial Summary for Histidine

Top disease conditions for Histidine
Top clinical trial sponsors for Histidine

See all Histidine clinical trials

US Patents for Histidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Histidine   Start Trial Nuclear targeting sequences Yeda Research and Development Co. Ltd. (Rehovot, IL)   Start Trial
Histidine   Start Trial Fluorogenic semiconductor nanocrystals LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA)   Start Trial
Histidine   Start Trial Seaweed-derived cosmetic compositions Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA)   Start Trial
Histidine   Start Trial Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR)   Start Trial
Histidine   Start Trial Combination therapies for cancer MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Histidine

Drugname Country Document Number Estimated Expiration Related US Patent
Histidine European Patent Office EP2134373 2027-02-28   Start Trial
Histidine European Patent Office EP2839839 2027-02-28   Start Trial
Histidine Spain ES2662036 2027-02-28   Start Trial
Histidine Israel IL200578 2027-02-28   Start Trial
Histidine Israel IL219783 2027-02-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Boehringer Ingelheim
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.